Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
Crossref DOI link: https://doi.org/10.1038/bcj.2016.27
Published Online: 2016-05-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Z
Wang, W
Cortes, J E
Liu, E
Miranda, R N
Zhao, C
Yuan, J
Lu, X
Yang, W
Ameri, M D
Kantarjian, H M
Medeiros, L J
Hu, S
Text and Data Mining valid from 2016-05-06
Version of Record valid from 2016-05-06
Article History
First Online: 6 May 2016
Competing interests
: The authors declare no conflict of interest.